OK SB1658

Drug manufacturers must prepare plain-language summaries of known or reasonably suspected side effects and adverse events for all drugs, vaccines, and biologics distributed in Oklahoma, including rare but serious effects, and submit them to the State Board of Pharmacy for public posting.

Hospitals and health care providers must provide patients or guardians with the manufacturer's current side effect summary before administering or prescribing any drug, vaccine, or biologic.

Suspected adverse events must be documented in electronic medical records and reported to the State Board of Pharmacy within 10 business days; retaliation against employees who report in good faith creates joint and several liability.

Patients may bring civil actions for damages and attorney fees against manufacturers, hospitals, or providers who negligently fail to comply; the Attorney General may pursue actions under the Oklahoma Consumer Protection Act for patterns of noncompliance.

Effective date: November 1, 2026.